BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 10526665)

  • 21. [Treatment of relapses and failures in disseminated Hodgkin's disease].
    Bastion Y; Tigaud JD; Coiffier B
    Presse Med; 1991 Nov; 20(35):1733-6. PubMed ID: 1721717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
    Al-Ali HK; Wittekind C; Niederwieser D
    Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug selection in the treatment of Hodgkin's disease.
    Bonadonna G; Santoro A
    Hematol Oncol; 1983; 1(1):3-12. PubMed ID: 6203820
    [No Abstract]   [Full Text] [Related]  

  • 24. Optimal treatment of early-stage Hodgkin disease.
    Sullivan JW; Cooper JS
    Radiology; 1993 Feb; 186(2):312-3. PubMed ID: 7678466
    [No Abstract]   [Full Text] [Related]  

  • 25. ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.
    Clamon GH; Corder MP
    Cancer Treat Rep; 1978 Mar; 62(3):363-7. PubMed ID: 77188
    [No Abstract]   [Full Text] [Related]  

  • 26. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
    Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
    Dtsch Med Wochenschr; 1976 Aug; 101(32):1177-82. PubMed ID: 59661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early intensification treatment approach in advanced-stage Hodgkin lymphoma.
    Borchmann P
    Hematol Oncol Clin North Am; 2014 Feb; 28(1):65-74. PubMed ID: 24287068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytostatic chemotherapy of lymphogranulomatosis].
    Dold U
    Dtsch Med Wochenschr; 1978 Feb; 103(6):235-8. PubMed ID: 75085
    [No Abstract]   [Full Text] [Related]  

  • 29. Etoposide, vinblastine, adriamycin and prednisolone (EVAP) combination chemotherapy as first-line treatment for Hodgkin's disease.
    Raina V; Sharma A; Mohanti BK; Kumar R; Dawar R; Rath GK
    Natl Med J India; 2003; 16(4):199-203. PubMed ID: 14606767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome of children and adolescents treated with the COPP-ABV hybrid protocol for Hodgkin's disease: balance of risks.
    Klumb CE; Carriço MK; de Rezende LM; Byington R; Bordallo MA; Bigni RS; Apa AG; Dobbin JA
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):628-9. PubMed ID: 17662581
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative study of advanced-stage Hodgkin's lymphoma patients treated with either COPP or ABVD drug combinations].
    Molnár Z; Fleischmann T
    Orv Hetil; 1992 Jun; 133(25):1561-3. PubMed ID: 1383902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
    Sagar TG; Chandra A; Raman SG
    Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cancer of the testis after Hodgkin's disease. Apropos of 2 cases].
    Robert M; Averous M; Lavabre-Bertrand T; Iborra F; Chevallier P; Rebillard X; Guiter J; Grasset D
    J Urol (Paris); 1992; 98(3):178-80. PubMed ID: 1282922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
    Bonadonna G
    Cancer Res; 1982 Nov; 42(11):4309-20. PubMed ID: 6181867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease.
    Keskin EY; Gursel T; Uluoglu O; Albayrak M; Kaya Z; Coskun U; Kocak U
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):e294-6. PubMed ID: 20736843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current approaches to the treatment of advanced-stage Hodgkin's disease.
    Rusthoven JJ
    CMAJ; 1986 Sep; 135(5):465-73. PubMed ID: 2427176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug therapy of malignant lymphoma].
    Ogawa M; Inagaki J
    Rinsho Hoshasen; 1985 Oct; 30(11):1317-32. PubMed ID: 2418229
    [No Abstract]   [Full Text] [Related]  

  • 38. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
    Arakelyan N; Berthou C; Desablens B; de Guibert S; Delwail V; Moles MP; Quittet P; Jais JP; Colonna P; Andrieu JM;
    Cancer; 2008 Dec; 113(12):3323-30. PubMed ID: 18988286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Concomitant pulmonary Langerhans cell histiocytosis and malignant lymphoma: report of two cases].
    Régis A; Ben Salem D; Lambert A; Couaillier JF; Casasnovas O; Piard F; Krausé D
    J Radiol; 2009 Jan; 90(1 Pt 1):66-8. PubMed ID: 19182717
    [No Abstract]   [Full Text] [Related]  

  • 40. Escalated BEACOPP in advanced Hodgkin's lymphoma.
    Casasnovas O; Coiffier B
    Lancet; 2012 May; 379(9828):1767-8. PubMed ID: 22480757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.